Skip to main content
Home Home
  • Learn
    • TraceLink
    • Opus Platform
    • Agile supply chain
    • Customers
    • Partners
    • TraceLink University
    • Support
    • About Us
  • Share
    • Catalog
    • Community
    • Events
Home Home

Network

  • All Networks
    • More coming soon
  • Team
  • Process
    • Log in
      • TraceLink Classic

        app.tracelink.com

Agile Supply Chain

  • The Agile Imperative
  • Insights
  • Resources
Back
  • PDF
  • Share
    • LinkedIn
    • Twitter
    • Facebook
    • Mail

Case Study: TraceLink | FDA Pilot - Product Traceability Under 2023 DSCSA Regulations - A Business Process-Led Design for a Blockchain Network

October 28, 2019

TraceLink's breakthrough blockchain solution, Trace Histories, can help pharma clients comply with US Drug Supply Chain Security Act regulations which go into effect in 2023. With Trace Histories, customers can respond to product trade requests while simultaneously safeguarding confidential commercial information. Read our new poster, which was featured at FutureLink Nashville, for additional details. 

TraceLink Poster

 
View Poster Session Gallery

 

 
Case Study,
DSCSA,
Technology
Related Content
DSCSA Saleable Returns: Critical 2019 Decisions for India Manufacturers
Watch this webinar series to learn how India manufacturers should prepare for DSCSA saleable returns with live Q&A in Hindi and English.
Solving Saleable Returns: Critical Steps Toward Meeting the Deadline
In this webinar series, TraceLink experts will guide you through the maze of saleable returns and product verification:
Transforming the Health System Pharmacy Supply Chain Through DSCSA
Watch this on-demand webinar to learn how health system pharmacies are driving new value from compliance.
  • Legal & Trust
  • Contact Us
  • Careers
  • Sitemap

© TraceLink Inc. 2009-2021 All Rights Reserved

  • Log in
    • TraceLink Classic

      app.tracelink.com

  • Legal & Trust
  • Contact Us
  • Careers
  • Sitemap